Progesterone – promoter or inhibitor of breast cancer
- 20 February 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Climacteric
- Vol. 16 (sup1), 54-68
- https://doi.org/10.3109/13697137.2013.768806
Abstract
Based on the results of a French cohort of postmenopausal women, it has been claimed that micronized progesterone does not enhance breast cancer risk. The impact of reproductive factors on breast cancer risk and a high prevalence of occult breast carcinomas at the time of menopause suggest an involvement of endogenous progesterone in the development of breast cancer. High mammographic density in the luteal phase and during treatment with estrogen/progestogen combinations reflect a change in the composition of mammary stroma and an increased water accumulation in the extracellular matrix which is caused by hygroscopic hyaluronan–proteoglycan aggregates. Proteoglycans are also involved in the regulation of proliferation, migration, and differentiation of epithelial cells and angiogenesis, and may influence malignant transformation of breast cells and progression of tumors. Reports on a lack of effect of estrogen/progesterone therapy on breast cancer risk may be rooted in a selective prescription to overweight women and/or to the very low progesterone serum levels after oral administration owing to a strong inactivation rate. The contradictory results concerning the proliferative effect of progesterone may be associated with a different local metabolism in normal compared to malignant breast tissue. Similar to other progestogens, hormone replacement therapy with progesterone seems to promote the development of breast cancer, provided that the progesterone serum levels have reached the threshold for endometrial protection.Keywords
This publication has 95 references indexed in Scilit:
- Estrogen and Progesterone in Normal Mammary Gland Development and in CancerHormones and Cancer, 2010
- Hormone replacement therapy (HRT), breast cancer and tumor pathologyMaturitas, 2010
- Breast cancer: Are oestrogen metabolites carcinogenic?Maturitas, 2007
- Hormones and progeny of breast tumor cellsClimacteric, 2006
- Steroid receptors in human breast cancerTrends in Endocrinology & Metabolism, 2004
- Steroid Receptors and Cell Cycle in Normal Mammary EpitheliumJournal of Mammary Gland Biology and Neoplasia, 2004
- Declining Estrogen Receptor-β Expression Defines Malignant Progression of Human Breast NeoplasiaThe American Journal of Surgical Pathology, 2003
- Progesterone Receptors in Mammary Gland Development and TumorigenesisJournal of Mammary Gland Biology and Neoplasia, 2003
- Oestrogen receptor alpha in female fetal, infant, and child mammary tissueThe Journal of Pathology, 2000
- Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breastBritish Journal of Cancer, 1981